By KATIE THOMAS
The study found evidence of “adverse tiering,” or placing all of the drugs used to treat H.I.V. in a specialty tier, where consumers are required to pay at least 30 percent of the cost of the drug.
Published: January 29, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1zdVPSt
from WordPress http://ift.tt/1yzWry5
via Hadi Aboukhater
No comments:
Post a Comment